Amy L. Billett

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation”.

Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation

Journal of Clinical Oncology(2021)10.1200/jco.20.03286

N/A

2.4DataRank · unranked

59 citations

Michael P. Link, Amy L. Billett, Jamie E. Flerlage, John T. Lucas, Belinda N. Mandrell +16 more

Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2019001256

N/A

0DataRank · unranked

9 citations

Amy Saur Conway, Amanda L. Robichaud, Samuel Kitara, Alanna J. Church, Alyssa L. Kennedy +6 more